🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
OBJECTIVES: I. Evaluate the presumed mechanism of action of low dose pergo...
Status
Completed
Location
Multiple Locations
Start Date
1994-12
Trial ID
NCT00004433
Treatments Being Tested
Hypothesis: Schizotypal personality disorder patients will show cognitive i...
Status
Unknown
Location
Mount Sinai School of Medicine
Start Date
2000-10
Trial ID
NCT00252044
Treatments Being Tested
Dopamine has been closely associated with prefrontal function. The hypothes...
Status
Suspended
Location
Hamamatsu University Hospital
Start Date
2003-03
Trial ID
NCT00197483
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pergoli...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
1995-10
Trial ID
NCT00000269
Treatments Being Tested
Parkinson's disease is a major neurodegenerative disorder in which there is...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-11
Trial ID
NCT00605683
Treatments Being Tested
The purpose of this study is to evaluate the effects of pergolide on cocain...
Status
Completed
Location
Columbia University
Start Date
TBD
Trial ID
NCT00000215
Treatments Being Tested
This compassionate use study is designed to monitor safety in patients who ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00624741
Treatments Being Tested
The objective of this study is to compare the modulation of pergolide, a D1...
Status
Completed
Location
Zentralinstitut für Seelische Gesundheit
Start Date
2003-10
Trial ID
NCT01066403
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pergoli...
Status
Completed
Location
Medical University of South Carolina
Start Date
1996-02
Trial ID
NCT00000248
Treatments Being Tested